ReviewClinical and experimental gastroenterology2023

Clinical Evaluation of Upadacitinib in the Treatment of Adults with Moderately to Severely Active Ulcerative Colitis (UC): Patient Selection and Reported Outcomes.

Malcolm Irani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.